April 2011
Volume 52, Issue 14
Free
ARVO Annual Meeting Abstract  |   April 2011
Ex Vivo Expansion Of Bone Marrow Derived Cells From Normal Human Cornea
Author Affiliations & Notes
  • Jing Hua
    Ophthalmology, Schepens Eye Research Institute/Harvard Medical School, Boston, Massachusetts
  • Takaaki Hattori
    Ophthalmology, Schepens Eye Research Institute/Harvard Medical School, Boston, Massachusetts
  • Sandhya Sharma
    Ophthalmology, Schepens Eye Research Institute/Harvard Medical School, Boston, Massachusetts
  • Francisco Amparo
    Ophthalmology, Schepens Eye Research Institute/Harvard Medical School, Boston, Massachusetts
  • Narghes Calcagno
    Ophthalmology, Schepens Eye Research Institute/Harvard Medical School, Boston, Massachusetts
  • Daniel Saban
    Ophthalmology, Schepens Eye Research Institute/Harvard Medical School, Boston, Massachusetts
  • Reza Dana
    Ophthalmology, Schepens Eye Research Institute/Harvard Medical School, Boston, Massachusetts
  • Footnotes
    Commercial Relationships  Jing Hua, None; Takaaki Hattori, None; Sandhya Sharma, None; Francisco Amparo, None; Narghes Calcagno, None; Daniel Saban, None; Reza Dana, None
  • Footnotes
    Support  NIH/NEI F32-018292 (Saban); NIH/NEI R01-12963 (Dana)
Investigative Ophthalmology & Visual Science April 2011, Vol.52, 1116. doi:
  • Views
  • Share
  • Tools
    • Alerts
      ×
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      Jing Hua, Takaaki Hattori, Sandhya Sharma, Francisco Amparo, Narghes Calcagno, Daniel Saban, Reza Dana; Ex Vivo Expansion Of Bone Marrow Derived Cells From Normal Human Cornea. Invest. Ophthalmol. Vis. Sci. 2011;52(14):1116.

      Download citation file:


      © ARVO (1962-2015); The Authors (2016-present)

      ×
  • Supplements
Abstract

Purpose: : Hematopoietic bone marrow derived cells differentiate into leukocyte types, e.g. antigen presenting cells (APC), and then migrate through or take up and residence in peripheral tissue, e.g. cornea. Interestingly, a considerable number of bone marrow derived cells in the normal cornea exhibit a ‘precursor’ phenotype (e.g., CD14+, Sca-1+, CD34+); however, their capacity to expand and/or differentiate into APCs is incompletely understood and we thus began to investigate this here.

Methods: : Human corneas were obtained, pooled and separated into cornea, limbus and bulbar conjunctiva. Tissues were collagenase digested into single-cells and respectively plated (10^5/ml). Expansion was driven by addition of hematopoietins (50ng/ml GMCSF and 50ng/ml IL-4, replenished every 48-72hr) in complete RPMI for 2 weeks. Negative controls were plated in the absence of hematopoietins. Another negative control used were human dermal fibroblasts plated in the presence of hematopoietins. The positive control was served by plating human peripheral blood monocytic cells (PBMC) in the presence of hematopoietins. Cultures were followed via inverted microscopy for evidence of expansion, and cells were harvested after 14d and assessed via FACS for relevant APC markers.

Results: : Limbal cells plated with hematopoietins did not show significant expansion since percent CD45+ cells increased only marginally, relative to limbal cells plated without hematopoietins (5.9% vs. 2.1%, respectively). Similarly, while no significant expansion was observed in conjunctival cells plated with hematopoietins, a 10-fold increase in CD45+ cells (22%) was observed for corneal cells plated with hematopoietins. These CD45+ cells from cornea cultures were also CD11b+ CD11c+, thus suggesting a myeloid dendritic cell (DC) differentiation, and expressed HLA DR+ CD86+. Interestingly, however, the mean fluorescence intensity of HLA DR+ CD86+ was considerably lower than levels expressed by CD11b+ CD11c+ DCs differentiated from PBMC, even after 24hr LPS stimulation.

Conclusions: : These data suggest that cornea possesses bone marrow derived cells at a functional precursor state, and capable of expanding and differentiating into DCs. Furthermore, consistent with the function of corneal DCs in vivo, putative ex vivo expanded DCs also appear to be resistant to phenotypic maturation.

Keywords: immunomodulation/immunoregulation • immune tolerance/privilege • cornea: basic science 
×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×